Related references
Note: Only part of the references are listed.Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii
Ji Young Jang et al.
JOURNAL OF CRITICAL CARE (2017)
The Role of Aerosolized Colistin in the Treatment of Ventilator-Associated Pneumonia: A Systematic Review and Metaanalysis
Antonis Valachis et al.
CRITICAL CARE MEDICINE (2015)
Association Between Colistin Dose and Development of Nephrotoxicity
Yu-Ji Lee et al.
CRITICAL CARE MEDICINE (2015)
A review on colistin nephrotoxicity
Atefeh Ordooei Javan et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes
Ki Hwan Kwon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Pulmonary and Systemic Pharmacokinetics of Inhaled and Intravenous Colistin Methanesulfonate in Cystic Fibrosis Patients: Targeting Advantage of Inhalational Administration
Shalini W. S. Yapa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium
Felipe F. Tuon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections A narrative review for the clinician
Nihal Martis et al.
JOURNAL OF INFECTION (2014)
Effect of Aerosolized Colistin as Adjunctive Treatment on the Outcomes of Microbiologically Documented Ventilator-Associated Pneumonia Caused by Colistin-Only Susceptible Gram-Negative Bacteria
Mario Tumbarello et al.
CHEST (2013)
Incidence and Predictors of Nephrotoxicity Associated with Intravenous Colistin in Overweight and Obese Patients
Timothy P. Gauthier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?
Gamze Kalin et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa
Reinout Naesens et al.
BMC INFECTIOUS DISEASES (2011)
Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System
Jason M. Pogue et al.
CLINICAL INFECTIOUS DISEASES (2011)
Risk factors for colistin-associated nephrotoxicity
Pinyo Rattanaumpawan et al.
JOURNAL OF INFECTION (2011)
Renal and neurological side effects of colistin in critically ill patients
Herbert Spapen et al.
ANNALS OF INTENSIVE CARE (2011)
Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital
C. Andrew DeRyke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
Roberto Imberti et al.
CHEST (2010)
Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator-Associated Pneumonia: A Matched Case-Control Study
Diamantis P. Kofteridis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Multidrug-resistant Gram-negative infections: the use of colistin
Argyris S. Michalopoulos et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
Pinyo Rattanaumpawan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Effectiveness and safety of colistin: prospective comparative cohort study
Mical Paul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
Joshua D. Hartzell et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical characteristics and risk factors of colistin-induced nephrotoxicity
Jieun Kim et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Pharmacokinetics of inhaled colistin in patients with cystic fibrosis
F Ratjen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas et al.
CLINICAL INFECTIOUS DISEASES (2005)
Colistin interactions with the mammalian urothelium
JR Lewis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
The origin of the ideal body weight equations
MP Pai et al.
ANNALS OF PHARMACOTHERAPY (2000)